Operating as an integrated contract development and manufacturing organization (CDMO), Scorpius Holdings Inc. primarily conducts its business through its subsidiary, Scorpius BioManufacturing. The company offers a comprehensive array of services to pharmaceutical and biotechnology enterprises, spanning analytical testing, downstream process development, formulation optimization, and clinical biomanufacturing. Additionally, Scorpius Holdings supports clients with pre-clinical and product development, provides analytical assistance for Chemistry, Manufacturing, and Control (CMC), and performs various bioassays. Established in Morrisville, North Carolina, and incorporated in 2008, the company adopted its current name in February 2024, having previously been known as NightHawk Biosciences, Inc.
